Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
Brian Bressler, Jennifer Jones, Tracy S. H. In, Tommy Lan, Cristian Iconaru, John K. Marshall
Topics & Concepts
UstekinumabMedicinePersistence (discontinuity)Internal medicineHazard ratioProportional hazards modelInflammatory bowel diseaseUlcerative colitisCrohn's diseaseConfidence intervalPopulationRetrospective cohort studyDiseaseGastroenterologyAdalimumabGeotechnical engineeringEnvironmental healthEngineeringInflammatory Bowel DiseaseAutoimmune and Inflammatory DisordersMicroscopic Colitis